Clinical Study
Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer
Table 5
Subgroup analysis after DEB-TACE.
| Alive | Total embolizations | Number; percent | Previous failed chemotherapy | Number; percent | ECOG | Number; percent | Extrahepatic metastases | Number; percent | QoL | Number; percent | SAEs [ = 8] | Percentage |
| = 6 | 1 2 3 | 4; 66% 1; 16% 1; 16% Mean = 1.5 | 1 2 3 4 5 | 2; 34% 3; 50% 1; 16% 0 0 Mean = 1.8 | 0 1 2 n/a | 4; 66% 1; 16% 1; 16% 0 Mean = 0.5 | Y N | 3; 50% 3; 50% | Stable Delayed Immediate n/a | 3; 50% 1; 16% 0 2; 34% | 0 | 0 |
| OS < 5 months | Total embolizations | Number; percent | Previous failed chemotherapy | Number; percent | ECOG | ā | Extrahepatic metastases | Number; percent | QoL | Number; percent | SAEs = 8 | SAEs = 8 |
| = 12 | 1 2 3 | 7; 58% 4; 33% 1; 9% Mean = 1.3 | 1 2 3 4 5 | 5; 41% 5; 41% 1; 9% 1; 9% 0 Mean = 1.8 | 0 1 2 n/a | 8; 67% 2; 16% 0 2; 16% Mean = 0.15 | Y N | 4; 34% 8; 66% | Stable Delayed Immediate n/a | 7; 58% 2; 16% 2; 16% 1; 9% | 7 | 87.5% |
| OS < 5 months | Total embolizations | Number; percent | Previous failed chemotherapy | Number; percent | ECOG | ā | Extrahepatic metastases | Number; percent | QoL | Number; percent | SAEs = 8 | SAEs = 8 |
| = 9 | 1 2 3 | 9; 100% 0 0 Mean = 1.0 | 1 2 3 4 5 | 1; 11% 5; 55% 1; 11% 1; 11% 1; 11% Mean = 2.5 | 0 1 2 n/a | 2; 22% 6; 66% 1; 11% 0 Mean = 0.9 | Y N | 4; 44% 5; 56% | Stable Delayed Immediate n/a | 0 2; 22% 6; 67% 1; 11% | 1 | 12.5% |
|
|